Christoph Sossou, MD
Cardiovascular Disease · Morristown, NJNPI 1386185569
Payments from drug & device makers
What this record shows
This record is dominated by grants: $13,121 of the $20,386 with a category attached, or 64.4%. 32 manufacturers reported payments, led by Medtronic at 41.7% of the total. Reporting peaked in 2023 at $14,670 and has fallen 78.5% since, to $3,151 in 2025. Among cardiovascular disease clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 118 payments — averaging $172.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$8K
- Abbott$6K
- Cvrx, Inc.$2K
- Boston Scientific$774
- Abiomed$469
- Shockwave Medical, Inc$406
- plus $2K from 26 others
What the payments were for
- Grants$13,12164%
- Travel & lodging$1,99910%
- Food & beverage$4,52322%
- Education$6683%
- Gifts$750%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 5 | $8,499 |
| Abbott | 33 | $6,224 |
| Cvrx, Inc. | 13 | $1,708 |
| Boston Scientific | 3 | $774 |
| Abiomed | 4 | $469 |
| Shockwave Medical, Inc | 2 | $406 |
| Lantheus Medical Imaging, Inc. | 11 | $242 |
| Merck | 6 | $241 |
| Chiesi USA, Inc. | 3 | $231 |
| Johnson & Johnson | 3 | $188 |
| Esperion Therapeutics, Inc. | 2 | $165 |
| E.r. Squibb & Sons, L.L.C. | 3 | $147 |
| Astellas Pharma US Inc | 3 | $145 |
| Edwards Lifesciences | 1 | $131 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 6 | $131 |
| Pfizer | 1 | $124 |
| Eurofins Viracor, LLC | 1 | $108 |
| Impulse Dynamics (USA) Inc. | 1 | $76 |
| Cook Medical LLC | 1 | $49 |
| Penumbra, Inc. | 1 | $48 |
| Bridgebio Pharma, Inc. | 2 | $38 |
| Alnylam Pharmaceuticals Inc. | 2 | $36 |
| Livanova USA, Inc. | 1 | $35 |
| Cardiovascular Systems Inc. | 2 | $27 |
| Canon Medical Systems USA, Inc. | 1 | $24 |
| Daiichi Sankyo Inc. | 1 | $22 |
| Bayer | 1 | $21 |
| Teleflex LLC | 1 | $19 |
| Boehringer Ingelheim | 1 | $17 |
| Novartis | 1 | $14 |
| Amgen | 1 | $14 |
| AstraZeneca | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Barostim Neo System$1,392
- CARDIOMEMS$855
- Impella$444
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$406
- GENERAL ATHERECTOMY$349
- ONYX FRONTIER$164
- AVVIGO Guidance System$154
- XIENCE SKYPOINT$147
- XARELTO$133
- Telescope$128
- OPTIS$125
- SYMPLICITY G3$124
- VYNDAQEL$124
- NEXLIZET$122
- NEXLETOL$122
- CAMZYOS$118
How this compares
$20,386 in reported general payments places this provider in the 90th percentile of 1,006 cardiovascular disease providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rosuvastatin Calcium | 28 | $538 |
| ClopidogrelClopidogrel Bisulfate | 23 | $264 |
| Atorvastatin Calcium | 17 | $142 |
| Losartan Potassium | 11 | $128 |
| Furosemide | 23 | $100 |
| Carvedilol | 13 | $87 |
| Amlodipine Besylate | 19 | $79 |
| Spironolactone | 12 | $49 |
| Metoprolol Tartrate | 13 | $48 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Morristown
- Gennaro GiustinoMorristown$135K
- Konstantinos KoulogiannisMorristown$123K
- Linda GillamMorristown$61K
- Robert KippermanMorristown$48K
- Marc CohenNewark$762K
- Peter FarrugiaColts Neck$600K
- Felix Dailey-SterlingGuttenberg$568K
- Ramzan ZakirNew Brunswick$342K
- Richard KovachBrowns Mills$300K
- Andrea RussoCamden$293K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.